Remove Clinical Development Remove Life Science Remove Radiology
article thumbnail

Bayer delivers on medical innovation fueling transformation of pharma business

The Pharma Data

At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients. “We Re-imagining Radiology.

article thumbnail

BioSpace Movers & Shakers, Nov. 20

The Pharma Data

Previously, Baffa was Therapeutic Area Head of Oncology, Global Clinical Development for Shire. Hojvat served as the director of the Division of Microbiology Devices at the Center for Devices and Radiological Health at the Food and Drug Administration for 12 years. Source link.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024

Intouch Solutions

The discourse wasn’t just about cycling through tissue or aiding clinical development; it ranged from mutation prediction to tumor microenvironment (TME) analysis to how AI can aid in diagnosis and treatment planning to achieve better outcomes for patients. This is Pharmaphorum web editor Nicole Raleigh.

DNA 59
article thumbnail

Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals

XTalks

Advantages of Alpha Emitter Therapy Over the past two decades, the radiological and chemical properties of alpha emitting isotopes have regained prominence in medical physics. Alpha particle therapy represents a significant advancement in cancer treatment, reflecting the growing trend in oncology towards personalized and precision medicine.

DNA 66
article thumbnail

Women’s Health Clinical Trials: Clinical Innovations, Opportunities and Considerations

XTalks

Jansen recently moderated a webinar in which her colleagues at Medpace discussed the evolving women’s health sector, including the historical challenges and emerging trends in clinical development. A thorough analysis of the disease’s complexity, including pathophysiology, natural history and treatment landscape, is essential.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

Below are some free webinars you can register for that have delved into the topic: Continuing Clinical Research Innovations After COVID-19. The Impact of COVID-19 on Early Clinical Development – What the New Landscape Will Look Like. Addressing the Rapidly Evolving Vaccine Development Landscape. Drugs and Vaccines.